{"id":"NCT00150969","sponsor":"University Health Network, Toronto","briefTitle":"Vitamin K Supplementation in Post-Menopausal Osteopenia","officialTitle":"Evaluation of the Clinical Use of Vitamin K Supplementation in Post-Menopausal Women With Osteopenia (ECKO Trial)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-01","primaryCompletion":"2006-09","completion":"2007-09","firstPosted":"2005-09-08","resultsPosted":"2012-03-26","lastUpdate":"2023-12-28"},"enrollment":440,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Post-Menopausal Osteoporosis","Post-Menopausal Osteopenia"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"vitamin K1 (phylloquinone)","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"placebo","otherNames":[]}],"arms":[{"label":"phyloquinone","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether supplementation with 5 mg vitamin K daily over a 2-year period will prevent bone loss in post-menopausal women with osteopenia.","primaryOutcome":{"measure":"Percent Change in Bone Mineral Density (BMD) at the Lumbar Spine (L1-L4) Between Treatment Arms.","timeFrame":"0 to 24 months","effectByArm":[{"arm":"Phyloquinone","deltaMin":-1.28,"sd":3.5},{"arm":"Placebo","deltaMin":-1.22,"sd":3}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["Canada"]},"refs":{"pmids":["18922041"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":217},"commonTop":["nausea and vomitting"]}}